BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 17767159)

  • 1. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15.
    Menzel S; Garner C; Gut I; Matsuda F; Yamaguchi M; Heath S; Foglio M; Zelenika D; Boland A; Rooks H; Best S; Spector TD; Farrall M; Lathrop M; Thein SL
    Nat Genet; 2007 Oct; 39(10):1197-9. PubMed ID: 17767159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
    Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
    Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
    Bauer DE; Orkin SH
    Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
    Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
    Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.
    Solovieff N; Milton JN; Hartley SW; Sherva R; Sebastiani P; Dworkis DA; Klings ES; Farrer LA; Garrett ME; Ashley-Koch A; Telen MJ; Fucharoen S; Ha SY; Li CK; Chui DH; Baldwin CT; Steinberg MH
    Blood; 2010 Mar; 115(9):1815-22. PubMed ID: 20018918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
    Uda M; Galanello R; Sanna S; Lettre G; Sankaran VG; Chen W; Usala G; Busonero F; Maschio A; Albai G; Piras MG; Sestu N; Lai S; Dei M; Mulas A; Crisponi L; Naitza S; Asunis I; Deiana M; Nagaraja R; Perseu L; Satta S; Cipollina MD; Sollaino C; Moi P; Hirschhorn JN; Orkin SH; Abecasis GR; Schlessinger D; Cao A
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1620-5. PubMed ID: 18245381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress on genes related to fetal hemoglobin quantitative trait].
    Guo XQ
    Yi Chuan; 2010 Apr; 32(4):295-300. PubMed ID: 20423883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults.
    Thein SL; Menzel S; Peng X; Best S; Jiang J; Close J; Silver N; Gerovasilli A; Ping C; Yamaguchi M; Wahlberg K; Ulug P; Spector TD; Garner C; Matsuda F; Farrall M; Lathrop M
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11346-51. PubMed ID: 17592125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.
    Bhatnagar P; Purvis S; Barron-Casella E; DeBaun MR; Casella JF; Arking DE; Keefer JR
    J Hum Genet; 2011 Apr; 56(4):316-23. PubMed ID: 21326311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment.
    Funnell AP; Prontera P; Ottaviani V; Piccione M; Giambona A; Maggio A; Ciaffoni F; Stehling-Sun S; Marra M; Masiello F; Varricchio L; Stamatoyannopoulos JA; Migliaccio AR; Papayannopoulou T
    Blood; 2015 Jul; 126(1):89-93. PubMed ID: 26019277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing.
    Shen Y; Li R; Teichert K; Montbleau KE; Verboon JM; Voit RA; Sankaran VG
    PLoS Genet; 2021 Oct; 17(10):e1009835. PubMed ID: 34634037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering the genetics underlying foetal haemoglobin production in adults.
    Thein SL; Menzel S
    Br J Haematol; 2009 May; 145(4):455-67. PubMed ID: 19344402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of Sardinian beta0 thalassemia by genetic modifiers.
    Galanello R; Sanna S; Perseu L; Sollaino MC; Satta S; Lai ME; Barella S; Uda M; Usala G; Abecasis GR; Cao A
    Blood; 2009 Oct; 114(18):3935-7. PubMed ID: 19696200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
    Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
    Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the fetal hemoglobin silencing factor BCL11A.
    Basak A; Sankaran VG
    Ann N Y Acad Sci; 2016 Mar; 1368(1):25-30. PubMed ID: 26963603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Locus Models to Address Hb F Variability in Portuguese β-Thalassemia Carriers.
    Manco L; Bento C; Relvas L; Cunha E; Pereira J; Moreira V; Alvarez M; Maia T; Ribeiro ML
    Hemoglobin; 2020 Mar; 44(2):113-117. PubMed ID: 32319326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
    Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
    Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.